Price graphic per 18/10/19
Fund type: Fund of funds
Investment principle: Invests exclusively in equity funds with a focus on pharmaceutical/healthcare shares. Selection of funds in accordance with the Schoellerbank fund rating. Funds with different investment styles are put together (multi-manager approach). This reduces the risk while at the same time optimising earnings for fund of funds.
Investment aim: Long-term high level value growth
Investment horizon: Long-term
Risk of loss: high
Fund management: Schoellerbank Invest AG
ISIN: AT0000721501Fund volume: EUR 7.44 Mio. (30/08/2019)Information: launch date: 04/01/2001; first issue price: EUR 10.50; financial year: 01/07 - 30/06.; date of dividend: reinvestment; no dividends; date of payment: 1. bank working-day in SeptemberAccount deadline: issue / redemption price on the next stock exchange business day after the next Conditions: issue surcharge: 5%; management fee: 1.5% p.a. (included in fund price)Other information:registered for sale in GermanyNote: 19/06/2009: change of name from All Pharma to Schoellerbank Global Health Care